Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up (Q46135612)
Jump to navigation
Jump to search
scientific article published on 3 February 2009
Language | Label | Description | Also known as |
---|---|---|---|
English | Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up |
scientific article published on 3 February 2009 |
Statements
1 reference
Comparison of two doses of primary intravitreal bevacizumab (Avastin) for diffuse diabetic macular edema: results from the Pan-American Collaborative Retina Study Group (PACORES) at 12-month follow-up (English)
1 reference
Lihteh Wu
1 reference
J Fernando Arevalo
1 reference
Juan G Sanchez
1 reference
Maria H Berrocal
1 reference
Michel E Farah
1 reference
Jose Cardillo
1 reference
Francisco J RodrÃguez
1 reference
Pan-American Collaborative Retina Study Group (PACORES)
1 reference
3 February 2009
1 reference
247
1 reference
6
1 reference
735-743
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference